Trial · NCT02437383
Results by group82
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 82
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in the Weekly Mean Pain Index After 9 Weeks of Treatment | Propranolol ER | -13.9 | 95% Confidence Interval -17.4 to -10.5 | units on a scale | |
| Change in the Weekly Mean Pain Index After 9 Weeks of Treatment | Placebo | -12.1 | 95% Confidence Interval -15.5 to -8.7 | units on a scale | |
| Change in the Weekly Mean Pain Intensity After 9 Weeks of Treatment | Propranolol ER | -17.1 | 95% Confidence Interval -21.1 to -13.1 | units on a scale | |
| Change in the Weekly Mean Pain Intensity After 9 Weeks of Treatment | Placebo | -13.6 | 95% Confidence Interval -17.6 to -9.7 | units on a scale | |
| Change in the Weekly Mean Pain Duration After 9 Weeks of Treatment | Propranolol ER | -17.9 | 95% Confidence Interval -22.8 to -13.0 | units on a scale | |
| Change in the Weekly Mean Pain Duration After 9 Weeks of Treatment | Placebo | -16.6 | 95% Confidence Interval -21.3 to -11.7 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Affective Component After 9 Weeks of Treatment | Propranolol ER | -2.9 | 95% Confidence Interval -3.7 to -2.0 | score on a scale | |
| Change in the SF-McGill Pain Questionnaire Affective Component After 9 Weeks of Treatment | Placebo | -3.1 | 95% Confidence Interval -3.9 to -2.2 | score on a scale | |
| Change in the SF-McGill Pain Questionnaire Sensory Component After 9 Weeks of Treatment | Propranolol ER | -1.9 | 95% Confidence Interval -2.2 to -1.6 | score on a scale | |
| Change in the SF-McGill Pain Questionnaire Sensory Component After 9 Weeks of Treatment | Placebo | -1.6 | 95% Confidence Interval -1.9 to -1.2 | score on a scale | |
| Change in the SF-McGill Pain Questionnaire Present Facial Pain Intensity After 9 Weeks of Treatment | Propranolol ER | -0.9 | 95% Confidence Interval -1.1 to -0.7 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Present Facial Pain Intensity After 9 Weeks of Treatment | Placebo | -0.7 | 95% Confidence Interval -0.9 to -0.5 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Weekly Average Facial Pain Intensity After 9 Weeks of Treatment | Propranolol ER | -18.2 | 95% Confidence Interval -22.6 to -13.8 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Weekly Average Facial Pain Intensity After 9 Weeks of Treatment | Placebo | -15.8 | 95% Confidence Interval -20.1 to -11.5 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Weekly Average Facial Pain Duration After 9 Weeks of Treatment | Propranolol ER | -23.6 | 95% Confidence Interval -29.5 to -17.8 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Weekly Average Facial Pain Duration After 9 Weeks of Treatment | Placebo | -21.6 | 95% Confidence Interval -27.3 to -16.0 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Weekly Fatigue After 9 Weeks of Treatment | Propranolol ER | -12.0 | 95% Confidence Interval -17.7 to -6.3 | units on a scale | |
| Change in the SF-McGill Pain Questionnaire Weekly Fatigue After 9 Weeks of Treatment | Placebo | -11.4 | 95% Confidence Interval -16.9 to -5.8 | units on a scale | |
| Number of Participants Stratified Per Graded Chronic Pain Scale (GCPS) Grade After 9 Weeks of Treatment | Propranolol ER | GCPS Grades 0-IIa | 75 | Participants | |
| Number of Participants Stratified Per Graded Chronic Pain Scale (GCPS) Grade After 9 Weeks of Treatment | Placebo | GCPS Grades 0-IIa | 69 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02437383/results